Jabra Enhance Select 700 vs Lexie B2 Plus: Which OTC Hearing Aid?
By Lark Maple, Editor · Updated July 2026
SeniorPicks is reader-supported. As an Amazon Associate, we earn from qualifying purchases — when you buy through links on our site, we may earn a commission at no extra cost to you. This never affects our recommendations.
Jabra Enhance Select 700
The Jabra Enhance Select 700 is an FDA-cleared over-the-counter hearing aid for adults with perceived mild to moderate hearing loss, pairing self-fit devices with remote adjustments from a licensed specialist. Because untreated or misjudged hearing loss can have other causes, it is wise to get a hearing test first and confirm your loss falls in the OTC range. OTC aids are not medical treatment for severe loss, so anyone with sudden, one-sided, or significant loss should see an audiologist.
| Type | Receiver-in-ear OTC hearing aid (mild to moderate loss) |
|---|---|
| Fitting | Remote adjustments by licensed hearing specialist (video) |
| Battery | Rechargeable, 30+ hours per charge |
| Charging case | Holds ~3 full charges for on-the-go power |
| Connectivity | Bluetooth streaming, hands-free calls (iOS & Android) |
| Trial period | 100-day money-back guarantee |
| Support | 3 years of one-on-one video care included |
| Regulatory | FDA OTC hearing aid, not for severe/profound loss |
Lexie B2 Plus (Powered by Bose)
The Lexie B2 Plus is a self-fitting OTC hearing aid tuned with Bose technology, aimed at adults with mild to moderate hearing loss who prefer to set things up themselves through an app. A baseline hearing test is still recommended so you know your loss is in the OTC range and rule out medical causes. These are consumer devices, not a substitute for professional care, so persistent, worsening, or one-sided hearing loss should be checked by an audiologist.
| Type | Receiver-in-canal OTC hearing aid (mild to moderate loss) |
|---|---|
| Fitting | Self-fit via in-app hearing check (Bose tuning technology) |
| Battery | Rechargeable, up to 18 hours per charge |
| Charging time | About 3 hours to full |
| Programs | 4 environment presets plus up to 10 custom settings |
| Durability | IP57 splash and dust resistant |
| Connectivity | Bluetooth streaming for compatible iOS & Android |
| Regulatory | FDA OTC Class II device, ages 18+ |
Our verdict
Both are FDA-cleared OTC hearing aids for mild to moderate loss, but they serve different buyers. Choose the Jabra Enhance Select 700 if you want remote care from a licensed specialist, a long 100-day trial, and don't mind paying a premium. Choose the Lexie B2 Plus if you're comfortable self-fitting through an app, want strong Bose-tuned sound, and prefer to spend roughly half as much. Either way, get a hearing test first to confirm your loss is in the OTC range.
Frequently Asked Questions
- Jabra Enhance Select 700 or Lexie B2 Plus — which should I buy?
- Pick by how you want to be fitted, not by sound claims. The Jabra (about $1,995/pair) includes remote adjustments from a licensed specialist, 3 years of care, and a 100-day trial. The Lexie B2 Plus (about $999/pair) is fully self-fitting through an app with Bose tuning. If you want a person involved, pay the premium; if you are comfortable tuning them yourself, the Lexie does the same job for roughly half.
- Which has better battery life?
- The Jabra — 30+ hours per charge with a case holding about 3 more charges, versus about 18 hours and a 3-hour recharge on the Lexie. If you are regularly out for long days, that gap is the most practical difference between them.
- Are both suitable for severe hearing loss?
- No. Both are FDA-cleared OTC devices for adults with perceived mild to moderate loss only. Severe or profound loss, sudden loss, or loss noticeably worse in one ear needs an audiologist — an OTC device is the wrong tool and can delay finding a treatable cause.
- Can I try them before committing?
- The Jabra includes a 100-day money-back guarantee, which is unusually long and is a real part of what the higher price buys. Get a hearing test first either way, so you know your loss is in the OTC range before you start a trial clock.